Constipation, Diabetes, Hyperlipidemia, Hypertension, Pain
Conditions
Keywords
pharmacist, physician, primary care, collaboration, therapeutics
Brief summary
Recent health policy documents have endorsed an integrated model of collaboration between pharmacists and physicians in primary care. The integration of pharmacists into primary care has been identified as a priority for primary health care reform in Canada. However, the best way to do this has not been demonstrated or evaluated. This demonstration project shows the various ways in which pharmacists can be trained and integrated into different family practice settings, the processes and costs associated with doing this, and the outcomes observed. The main hypothesis is that pharmacist integration into family practice will optimize medication use, clinical care and clinical outcomes. This information provides policy makers with necessary information about collaboration between pharmacists and family physicians for their overall goal of reforming the delivery of primary health care to the population.
Detailed description
The overall goal of IMPACT was to improve patient outcomes by optimizing drug therapy through a community practice model that integrates pharmacists into family practices. This multi-site demonstration project involved 7 pharmacists, approximately 70 physicians and approximately 150,000 patients. Within each practice site, a pharmacist with special clinical training worked 2.5 days per week for 2 years and coordinated a multifaceted intervention aimed at optimizing drug therapy to improve patient outcomes (blood pressure, cholesterol, diabetes, pain control, constipation, etc.) The integrated pharmacist conducted patient assessments for medication problems, optimized office system medication management (e.g. develop process for handling of medication samples), and provided education (academic detailing ) focussed on key therapeutic areas. Pharmacists were provided with ongoing support from a training and mentorship program and the services of the Ontario Pharmacists' Association Drug Information Centre. The family physicians and other members of the practice worked closely with the pharmacist in implementing these strategic interventions. Family physicians from a range of practice models (Ontario Family Health Networks, Primary Care Networks, and other types of family physician group practices) participated in this project. Quantitative and qualitative methods were used to evaluate the process of integration, pharmacist service uptake, drug-related patient outcomes, and the costs associated with program implementation for sustainability. The integration of the physicians and pharmacists at the practice sites were evaluated with the aim of generating a practical and transferable practice model. The main hypothesis was that pharmacist integration into family practice will optimize medication use, clinical care and clinical outcomes.
Interventions
BEHAVIORALintegration of pharmacist into primary care
BEHAVIORALoptimizing processes of care
Sponsors
Hamilton Health Sciences Corporation
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
ECT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No
Inclusion criteria
65 + years and any two of the following: * Elevated blood pressure * Elevated hemoglobin A1C * Elevated LDL-C * Diagnosis of hypertension and no blood pressure readings in past 12 months * Diagnosis of diabetes and no hemoglobin A1C readings in past 12 months * Diagnosis of hyperlipidemia and no cholesterol readings in past 12 months * Diagnosis of osteoarthritis or rheumatoid arthritis * Using narcotics * Diagnosis of hypertension, diagnosis of diabetes and not using an ACE inhibitor * Diagnosis of hypertension, elevated blood pressure and using an NSAID * Diagnosis of hyperlipidemia, elevate dLDL-C and not using a lipid lowering agent * Diagnosis of hypertension, high blood pressure and not using a potassium wasting diuretic
Exclusion criteria
* Less than one visit to family physician in past 12 months * More than 20 visits to family physician in past 12 months * Awaiting placement to a nursing home or long-term care facility * Alcoholism * Palliative care patient * Family physician only sees patient as a home visit
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number and types of patients referred and assessed | — |
| Characterization and quantification of pharmacist activities | — |
| Numbers and types of drug-related problems identified and resolved | — |
| Medication changes made | — |
| Number of recommendations implemented | — |
| Process indicators (measurement of blood pressure, Cholesterol, hemoglobin A1C) | — |
| Surrogate clinical outcomes (values of blood pressure, Cholesterol, hemoglobin A1C) | — |
| Symptom improvement (constipation, pain) | — |
Secondary
| Measure | Time frame |
|---|---|
| Pharmacist and physician time costs | — |
| Space requirements | — |
| Health resource utilization | — |
| Health services utilization | — |
| Medication costs | — |
| Satisfaction with service | — |
| Uptake of pharmacist recommendations | — |
| Extent of knowledge translation | — |
| Extent of collaboration | — |
| Satisfaction with integrated pharmacist program | — |
| Set up costs | — |
| Travel cost | — |
Countries
Canada
Outcome results
None listed